As former NCI Director W. Kimryn Rathmell, MD, PhD, MMHC, embarks on the next stage of her career as CEO of the James Cancer ...

With more than 15,000 followers and 18,000 posts on X and a podcast called “Channel Your Enthusiasm” reviewing a classic text ...

Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

A consensus statement published in Endocrine Practice examines how health care professionals should approach treating and ...

There is a need to identify patients with obstructive sleep apnea after a weight-loss drug was approved for treatment of the ...

Biomarkers in blood and plasma can be used to predict rheumatoid arthritis-associated interstitial lung disease more ...

In this Healio Video Perspective from the ASCRS meeting, Marguerite B. McDonald, MD, discusses the efficacy of Miebo for dry ...

Monitoring blood levels of circulating tumor DNA in patients with stage 3 melanoma may accurately predict skin cancer ...

Five plasma proteins may predict a patient’s risk for metabolic dysfunction-associated steatotic liver disease up to 16 years ...

Patients with kidney disease may have their own reasons for not putting their faith in the health care system, but physicians ...

The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first ...

Visual acuity gradually improved for up to 5 years in patients with amblyopia, including adults, who were treated with ...